ALXN1830 in Patients With Warm Autoimmune Hemolytic Anemia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The main objective of the study is to evaluate the safety and efficacy of ALXN1830 compared to placebo in adult participants with warm autoimmune hemolytic anemia (WAIHA).
Epistemonikos ID: 0625095b8075415405df02ad159d8136d7603754
First added on: May 07, 2024